Associate Marketing Director, Oncology

Bridgewater, NJ (On-site)

$144K/yr – $216K/yrSenior Level8+ years expFull time

That's a $72K range! Where you land depends on how well you negotiate. Start practicing →

Posted 1 day ago

Job Summary

Original Job Description

Spend 15 mins, increase your paycheck by $15,000

$15,000 more per year. $45,000 over a 3-year tenure. One practice session with AI. That's the best ROI of any 15 minutes you'll spend this year.

Get Started

Recordati logo

Recordati

Recordati has been at the forefront of life-enhancing and life-changing medicines for almost 100 years.With its beginnings in a family run pharmacy in Correggio, Italy in the 1920s, Recordati is now a global pharmaceutical force, listed on the Italian stock exchange, with over 4,300 employees.We are a group of like-minded, passionate individuals who go to extraordinary lengths for our partners, customers, investors and the people across the globe who we serve. We develop and commercialise medicines to serve people living with common diseases, as well as those living with some of the rarest, in around 150 countries.At Recordati, our mantra is simple. We’ve always believed that health, and the opportunity to live life to the fullest, is a right, not a privilege. Whether that is for common diseases or the rarest – we want to give people the opportunity to be the best version of themselves.This drive will never stop. Together, we will always be reimagining tomorrow – with new ideas, new technologies and new innovations to fight diseases.Recordati. Unlocking the full potential of life.

Marketing team
278
Employees
4.1K
Headquarters
Milan, Lombardy, ITA
Founded
1926

Traffic Signals

Monthly Visitors
28.9K
Monthly Google Ads Budget
$0.0
Traffic Source Mix
Search
46.4%
Direct
35.8%
Referral
6.8%
Social
9.9%
Paid
0.9%

Headcount Trend

Current headcount: ~4.1K

Funding

Total Funding
$0.0
Last Raise
7 years ago
Last Raise Amount
  • 2018-12-01
    Undisclosed

Recent News

Morningstar.com
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9%
Jul 29, 2025
Recordati
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9%
Jul 29, 2025
Pharma Letter
The week in pharma: action, reaction and insight – week to June 27
Jun 29, 2025